• European Commission grants approval for Gotenfia®, a golimumab biosimilar to Simponi® that was developed by Bio-Thera ...
查看详情Avzivi® (BAT1706) is Bio-Thera Solution’second FDA approved product in the United StatesAvzivi® is the second biosimilar...
Theclinical comparative study met its primary endpoint and showed similar efficacyand comparable safety profile in patie...
GUANGZHOU,China, October 24, 2023 -- Bio-Thera Solutions, Ltd (688177:SH), acommercial-stage biopharmaceutical company d...
